NCT00102154撤回3 期
A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Study of MK0928 in Healthy Adult Volunteers Participating in a 4-Hour Phase Advance Model of Transient Insomnia
适应症
相关药物
试验速览
- 阶段
- 3 期
- 状态
- 撤回
- 主要终点
- 4-hour advanced polysomnographic (PSG) recording session measuring wake time after sleep onset (WASO) and latency to persistent sleep (LPS); Safety and tolerability
研究概览
简要总结
A study to evaluate the safety and effectiveness of an investigational drug for insomnia (a sleep disorder).
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Treatment
- 盲法
- Double (Participant, Investigator)
入排标准
- 年龄范围
- 18 Years 至 64 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy adults who are between the ages of 18 and 64
排除标准
- •Adults who are diagnosed with insomnia
结局指标
主要结局
4-hour advanced polysomnographic (PSG) recording session measuring wake time after sleep onset (WASO) and latency to persistent sleep (LPS); Safety and tolerability
次要结局
- Daily sleep diary for visual analogue sleep quality and number of night awakenings (sNAW)
研究者
相似试验
终止
3 期
Elderly Primary Insomnia Polysomnographic Study (0928-002)(TERMINATED)Primary InsomniaNCT00094666H. Lundbeck A/S465
终止
3 期
Adult Polysomnography Primary Insomnia Cross Over Study (0928-049)(TERMINATED)Primary InsomniaNCT00420810H. Lundbeck A/S138
已完成
4 期
The Treatment of Insomnia in Patients With HIV DiseaseInsomniaHIV InfectionsNCT00465972Duke University44
已完成
3 期
An Investigational Study of MK0928 in Adult Outpatients With Insomnia (0928-014)(COMPLETED)InsomniaNCT00103818H. Lundbeck A/S900
已完成
2 期
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011)Alzheimer's DiseaseNCT00420420Merck Sharp & Dohme LLC144